The Nazareth Hospital
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN) (NCT01564303) | The Nazareth Hospital | 2012-05-01 |
Track The Nazareth Hospital automatically
Every clearance here is in the API, with alerts when new ones post.